Francesca Gay

Associate Professor

University of Turin

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Ioannis Ntanasis-Stathopoulos

National and Kapodistrian University of Athens

GREECE

View details

Alberto Milan

Associate professor

University of Turin

ITALY

View details

ROBERTO MINA

Assistant professor

ITALY

View details

Evangelos Terpos

Professor of Hematology

National and Kapodistrian University of Athens - Faculty of Medicine

GREECE

View details

Joaquin Martinez-Lopez

SPAIN

View details

Bruno David Lourenço Paiva

Clinica Universidad de Navarra

SPAIN

View details

Lawrence Boise

Professor

Emory University

UNITED STATES

View details

david jaye

Associate Professor

Emory University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francesca Gay

Research Interests

Explore related searches

Contact this professor

Articles (10)

Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)

Patients with Very High Risk of Cardiovascular Adverse Events during Carfilzomib Therapy: Prevention and Management of Events in a Single Center Experience

MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials

Real-world treatment patterns, healthcare resource use and disease burden in patients with multiple myeloma in Europe

Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study

Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?

Antibody-drug conjugates: when chemotherapy meets immuno-oncology

The role of autologous stem-cell transplantation in multiple myeloma in 2021

MRD Assessment in Multiple Myeloma: Progress and Challenges

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents

Collaborators (8)

Ioannis Ntanasis-Stathopoulos

Alberto Milan

ROBERTO MINA

Evangelos Terpos

Joaquin Martinez-Lopez

Bruno David Lourenço Paiva

Lawrence Boise

david jaye

Make your next move.